Natus Medical Awarded Key New Government Contract

Rhea-AI Summary

Natus Medical (NASDAQ:NTUS) announced a significant achievement by securing a 5-year contract for its Patient Monitoring and Capital Equipment to be included in the United States government healthcare system's electronic catalog (ECAT). This contract, pre-vetted by the Defense Logistics Agency, enhances purchasing access for the Department of Defense and Veterans Affairs to a diverse range of Natus products, including neurodiagnostic and audiology equipment. The contract may extend for an additional five years, offering a streamlined transaction process to support military patients.

Positive

• 5-year contract awarded for inclusion in the ECAT, enhancing government purchase access.
• Streamlines purchasing process for Natus products, improving market reach to military healthcare systems.
• Potential extension of the contract for an additional 5 years, indicating long-term business opportunities.

Negative

• None.

Paves the Way for Purchase of Natus Medical Equipment Through United States Government Healthcare System Electronic Catalog

PLEASANTON, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, is pleased to announce the award of a 5-year contract to include Natus Patient Monitoring and Capital Equipment (PMCE) in the electronic catalog (ECAT). The PMCE contract is pre-established and pre-vetted by the Defense Logistics Agency (DLA) as a source for medical equipment and acts as a preferred purchasing source for United States government healthcare systems. ECAT, as an on-line ordering, distribution and payment solution facilitates over $1B in purchase activity annually.

The PMCE contract and ECAT integration will now provide easier access for the Department of Defense (DoD) and Veterans Affairs (VA) health systems to purchase many products across the Natus portfolio, including neurodiagnostic, audiology and newborn care equipment and supplies. The initial 5-year contract term also includes an additional 5-year extension option.

“We are excited to achieve this important milestone,” says Jonathan Kennedy, Natus CEO. “This agreement and Natus inclusion in the electronic catalog solution will dramatically improve the transaction process, making it easier for us to partner with government healthcare systems and provide our innovative solutions to the United States veteran and active-duty military patients in need.”  

About Natus Medical Incorporated

Natus Medical Incorporated improves patient outcomes using the most comprehensive product solutions, depth of training and continuing customer care when diagnosing and treating central nervous and sensory system disorders for patients of all ages.

Additional information about Natus Medical Incorporated can be found at https://natus.com.

Contacts:
Natus Medical Incorporated
Drew Davies
Executive Vice President and Chief Financial Officer
(925) 223-6700
InvestorRelations@Natus.com                

FAQ

What is the significance of Natus Medical's recent contract award?

Natus Medical secured a 5-year contract for its Patient Monitoring and Capital Equipment, allowing easier access for government healthcare systems to purchase its products.

How does the electronic catalog affect Natus Medical's business?

The inclusion in the electronic catalog enhances purchasing efficiency for the Department of Defense and Veterans Affairs, effectively expanding Natus Medical's market presence.

What types of products will be available through the ECAT for Natus Medical?

Products available will include neurodiagnostic, audiology, and newborn care equipment and supplies.

When was the contract for Natus Medical awarded?

The contract was announced on September 27, 2021.

What is Natus Medical's stock symbol?

Natus Medical is traded under the stock symbol NTUS.